Politics and Government Politics and Government
Wed, November 27, 2024
Tue, November 26, 2024
[ Tue, Nov 26th 2024 ] - Brian Stokes
Caroline Cummings
[ Tue, Nov 26th 2024 ] - Brian Stokes
Trust Matters in Cabinet Picks
Mon, November 25, 2024
Sun, November 24, 2024
Thu, November 14, 2024
Tue, November 12, 2024
Thu, April 23, 2009
Mon, February 2, 2009
[ Mon, Feb 02nd 2009 ] - Nathan Burkes
Is Obama a rock star?
Fri, January 30, 2009

OraSure Technologies to Participate at the Eleventh Annual Needham Growth Conference


Published on 2009-01-05 08:37:38, Last Modified on 2009-01-05 08:38:04 - Market Wire
  Print publication without navigation


BETHLEHEM, Pa.--([ BUSINESS WIRE ])--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the Eleventh Annual Needham Growth Conference in New York at approximately 10:30 am Eastern Time (7:30 am Pacific Time) on Wednesday, January 7, 2009. The conference will be simultaneously webcast over the Internet.

Interested investors can access the live audio webcast of the discussion by going to OraSure Technologies' web site, [ www.orasure.com ], and clicking on the Investor Information link. A replay of the audio webcast will be available until, January 14, 2009, on OraSure Technologies' web site.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to [ www.orasure.com ].


Publication Contributing Sources